Don’t Miss: Starbucks Corporation (NASDAQ:SBUX), Infinity Pharmaceuticals, Inc. (NASDAQ:INFI), Renren Inc. (NYSE:RENN), Express Scripts Holding Company (NASDAQ:ESRX), AbbVie Inc. (NYSE:ABBV)

Starbucks Corporation (NASDAQ:SBUX) belongs to Services sector. Its net profit margin is 14.60% and weekly performance is 2.52%. On last trading day company shares ended up $55.75. Starbucks Corporation (NASDAQ:SBUX) distance from 50-day simple moving average (SMA50) is 6.79%. On 13 July, Starbucks Corporation (NASDAQ:SBUX) said that, along with over a dozen of other companies are taking the initiative to provide employment to 100,000 workers with low-income backgrounds.

Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) shares increased 0.57% in last trading session and ended the day at $10.66. INFI return on assets is -63.10%. Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) quarterly performance is -28.93%. On 13 July, Pharmaceuticals, Inc. (NASDAQ:INFI) said that, it has been named 2015 Product of the Year in the feminine care category.

Renren Inc. (NYSE:RENN) belongs to Technology sector. Its net profit margin is 0.80% and weekly performance is 3.77%. On last trading day company shares ended up $3.58. Renren Inc. (NYSE:RENN) distance from 50-day simple moving average (SMA50) is -1.18%. Zacks upgraded shares of Renren Inc. (NYSE:RENN) from a sell rating to a hold rating in a research report released on Tuesday morning

Express Scripts Holding Company (NASDAQ:ESRX) ended the last trading day at $91.36. Company weekly volatility is calculated as 1.39% and price to cash ratio as 73.56. Express Scripts Holding Company (NASDAQ:ESRX) showed a weekly performance of 2.85%. On 2 July, Express Scripts Holding Company (NASDAQ:ESRX) announced data from the Exchange Pulse report, which compared prescription medication usage among exchange plan enrollees to patients enrolled in a traditional health plan between the first quarter of 2014 and the first quarter of 2015.

AbbVie Inc. (NYSE:ABBV) shares increased 0.33% in last trading session and ended the day at $69.80. ABBV Gross Margin is 79.40% and its return on assets is 6.50%. AbbVie Inc. (NYSE:ABBV) quarterly performance is 13.93%.On 13 July, AbbVie Inc. (NYSE:ABBV) announced a label expansion for its drug Imbruvica in the EU. Imbruvica gained EU approval for the treatment of adults with Waldenström’s macroglobulinemia (WM) who have undergone at least one prior therapy or as the first-line treatment for patients unsuitable for chemo-immunotherapy.

Leave a Reply

Your email address will not be published. Required fields are marked *